- Home
- BBAI vs INVA Comparison
BBAI vs INVA Comparison
Compare BBAI & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBAI
- INVA
- Stock Information
- Founded
- BBAI 2020
- INVA 1996
- Country
- BBAI United States
- INVA United States
- Employees
- BBAI N/A
- INVA N/A
- Industry
- BBAI EDP Services
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- BBAI Technology
- INVA Health Care
- Exchange
- BBAI Nasdaq
- INVA Nasdaq
- Market Cap
- BBAI 1.1B
- INVA 1.2B
- IPO Year
- BBAI N/A
- INVA 2004
- Fundamental
- Price
- BBAI $3.92
- INVA $18.58
- Analyst Decision
- BBAI Buy
- INVA Buy
- Analyst Count
- BBAI 4
- INVA 1
- Target Price
- BBAI $4.50
- INVA N/A
- AVG Volume (30 Days)
- BBAI 50.1M
- INVA 723.5K
- Earning Date
- BBAI 03-06-2025
- INVA 02-27-2025
- Dividend Yield
- BBAI N/A
- INVA N/A
- EPS Growth
- BBAI N/A
- INVA 46.55
- EPS
- BBAI N/A
- INVA 0.99
- Revenue
- BBAI $154,972,000.00
- INVA $352,745,000.00
- Revenue This Year
- BBAI $13.47
- INVA $16.20
- Revenue Next Year
- BBAI $16.32
- INVA N/A
- P/E Ratio
- BBAI N/A
- INVA $18.73
- Revenue Growth
- BBAI 0.01
- INVA 21.46
- 52 Week Low
- BBAI $1.17
- INVA $14.33
- 52 Week High
- BBAI $5.20
- INVA $21.28
- Technical
- Relative Strength Index (RSI)
- BBAI 55.23
- INVA 63.73
- Support Level
- BBAI $2.85
- INVA $17.01
- Resistance Level
- BBAI $4.79
- INVA $17.53
- Average True Range (ATR)
- BBAI 0.55
- INVA 0.28
- MACD
- BBAI -0.07
- INVA 0.18
- Stochastic Oscillator
- BBAI 45.53
- INVA 98.12
About BBAI BigBear.ai Inc.
BigBear.ai Holdings Inc is a technology-led solutions organization, that provides both software and services to its customers. Its AI-powered decision intelligence solutions are leveraged in three markets; supply chains & logistics, autonomous systems, and cybersecurity. It operates in two segments; Cyber & Engineering segment and Analytics segment.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.